Literature DB >> 29773115

Dispelling myths about drug procurement policy.

Marcel van Valen1, David Jamieson2, Lisa Parvin3, Cherie L Ramirez4.   

Abstract

Mesh：

Year:  2018        PMID： 29773115     DOI： 10.1016/S2214-109X(18)30190-6

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  5 in total

1.  Insulin prices, availability and affordability in 13 low-income and middle-income countries.

Authors:  Margaret Ewen; Huibert-Jan Joosse; David Beran; Richard Laing
Journal:  BMJ Glob Health       Date:  2019-06-11

2.  Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis.

Authors:  Cathrin Hauk; Simon Schäfermann; Peter Martus; Nigorsulton Muzafarova; Magali Babaley; Brenda Waning; Lutz Heide
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

3.  Consolidation or multiplicity in supply logistics for health commodities?

Authors:  Ebenezer Kwabena Tetteh
Journal:  Explor Res Clin Soc Pharm       Date:  2022-01-19

4.  The impacts of the "4+7" pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study.

Authors:  Xiaotong Wen; Zhaolun Wang; Luxinyi Xu; Jia Luo; Xin Geng; Xiaoze Chen; Ying Yang; Dan Cui; Zongfu Mao
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

5.  Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus.

Authors:  Jing Yuan; Z Kevin Lu; Xiaomo Xiong; Tai-Ying Lee; Huang Huang; Bin Jiang
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.